Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria Enugu Campus, Enugu, Nigeria.
Department of Community Medicine, University of Nigeria Enugu Campus, Enugu, Nigeria.
Health Expect. 2018 Feb;21(1):270-278. doi: 10.1111/hex.12612. Epub 2017 Aug 14.
The current trend of withdrawal of donor support for HIV/AIDS treatment in Nigeria may require that the cost of antiretroviral drugs be borne in part by infected people and their families.
This study was conducted to determine the economic value for free antiretroviral drugs (ARVs) expressed by clients receiving treatment for HIV/AIDS in a tertiary hospital.
The contingent valuation method was used to elicit the values attached to free ARVs from people living with HIV/AIDS that were receiving care in a public tertiary hospital in south-east Nigeria. Exit poll using a pre-tested questionnaire was undertaken with adult clients on treatment. The bidding game technique was used to elicit their willingness to pay (WTP) for ARVs for themselves and members of their households. Ordinary least squares (OLS) multiple regression analysis was used to test the construct validity of elicited WTP amounts.
About a third of the respondents were willing to pay for a monthly supply of ARVs for themselves and household members. The mean WTP for monthly supply of ARVs for self was US$15.32 and for household member was US$15.26 (1US$=₦160). OLS regression analysis showed that employment status and higher socio-economic status were positively associated with higher WTP. OLS showed that age and transport cost per clinic visit were negatively related to WTP. Knowing the risks of not adhering to treatment protocol was positively related to WTP.
The respondents positively valued the free ARVs. This calls for greater financial support for the sustainable provision of the treatment service. However, holistic financing mechanisms should be explored to ensure sustained funding in the event of complete withdrawal of donor support.
目前，尼日利亚撤回对艾滋病毒/艾滋病治疗的捐助支持的趋势可能要求艾滋病毒感染者及其家庭承担部分抗逆转录病毒药物的费用。
本研究旨在确定在尼日利亚东南部一家三级医院接受艾滋病毒/艾滋病治疗的患者对免费抗逆转录病毒药物（ARV）的经济价值。
采用条件价值评估法，从在尼日利亚东南部一家公立三级医院接受治疗的艾滋病毒感染者中获取对免费 ARV 的评价。对接受治疗的成年患者进行了出口民意调查，使用预先测试的问卷。使用投标博弈技术来了解他们为自己和家庭成员购买 ARV 的支付意愿（WTP）。采用普通最小二乘法（OLS）多元回归分析来检验所 elicite 的 WTP 金额的结构有效性。
约三分之一的受访者愿意为自己和家庭成员支付每月的 ARV 费用。每月自我 ARV 供应的平均 WTP 为 15.32 美元，家庭成员为 15.26 美元（1 美元=₦160）。OLS 回归分析表明，就业状况和较高的社会经济地位与较高的 WTP 呈正相关。OLS 表明，年龄和每次诊所就诊的交通成本与 WTP 呈负相关。了解不遵守治疗方案的风险与 WTP 呈正相关。
受访者对免费 ARV 给予了积极的评价。这需要为可持续提供治疗服务提供更多的财政支持。然而，应该探索全面的融资机制，以确保在完全撤回捐助支持的情况下能够持续获得资金。
